Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128675) titled 'Significance of Combining 68Ga-FAPI PET/CT, Clinical and Pathological Features in Predicting Pathological Response to Neoadjuvant Immunotherapy Combined with Chemotherapy for Locally Advanced Gastric Cancer' on July 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Patients with locally advanced gastric cancer receiving neoadjuvant chemoimmunotherapy.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: FAPI-PET/CT group:80;
Countries of Recruitment:
China
To know more...